The use of radiation therapy in the radical treatment of prostate cancer can lead to potential acute and long-term toxicity and health-related quality-of-life (HRQoL) changes. Ongoing investigation into dose-escalation, dose-per-fraction escalation, new radiation treatment technology/paradigms, and novel systemic therapy may have either positive and/or negative effects on normal tissue toxicity/HRQoL. Herein, common toxicity scales and HRQoL instruments that attempt to describe the deleterious effects of prostate radiation therapy are reviewed.
You are browsing the legacy CJU website. The journal is now
published by Tech Science Press, and the latest issues, articles and
submission information are available on our new website.